Qing-Jiang Li

Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer.

Yong Rao, Shuo-Bin Chen, Zhishu Huang, 2022, Journal of medicinal chemistry.